Depletion of brain histamine induced by α-fluoromethylhistidine enhances radial maze performance in rats with modulation of brain amino acid levels

Life Sciences

Volumn 62, Issue 11, 1998, Pages 989-994

  Sakai, Naruhiko ^a   Sakurai, Eitchi ^b   Sakurai, Eiko ^a   Yanai, Kazuhiko ^a   Miura, Yukio ^a,c   Watanabe, Takehiko ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

fluoromethylhistidine; Amino acids; GABA; Glutamate; Glycine; Histamine; Radial maze

Indexed keywords

ALPHA FLUOROMETHYLHISTIDINE; AMINO ACID; GLUTAMIC ACID; GLYCINE; HISTAMINE;

AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DIENCEPHALON; HIPPOCAMPUS; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; RAT; TASK PERFORMANCE;

AMINO ACIDS; ANIMALS; BRAIN; ENZYME INHIBITORS; HISTAMINE; HISTAMINE ANTAGONISTS; HISTIDINE DECARBOXYLASE; MALE; MAZE LEARNING; MEMORY; METHYLHISTIDINES; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0032488965     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00019-8     Document Type: Article

References (28)

1. 1. G. PRELL and D.E. GREEN, Ann. Rev. Neurosci. 9 209-254(1986)
2. 2. J.C. SCHWARTZ, J.M. ARRANG, M. GARBARG, H. POLLARD and M. RUAT, Physiol. Rev. 71 1-51(1990).
3. 3. T. WATANABE and H. WADA (Eds.), Histaminergic Neurons: Morphology and Function, 1-415, CRC Press, Boca Raton(1991).
4. 4. H. WADA, N. INAGAKI, A. YAMATODANI and T. WATANABE, Trends Neurol. Sci. 14 415-418 (1991).
5. 5. K. ONODERA, A. YAMATODANI, T. WATANABE and H. WADA, Prog. Neurol. 42 685-702 (1994).
6. 6. N. SAKAI, K. ONODERA, K. MAEYAMA, K. YANAI and T. WATANABE, Life Sci. 48 2397-2404(1991).
7. 7. N. SAKAI, K. ONODERA, K. MAEYAMA, K. YANAI and T. WATANABE, Life Sci. 51 397-405(1992).
8. 8. N. SAKAI, E. SAKURAI, K. ONODERA, E. SAKURAI, H. ASADA, Y. MIURA and T. WATANABE, Behav Brain Res. 72 83-88(1996).
9. 9. T. MOCHIZUKI, A. YAMATODANI, K. OKAKURA, A. HORII, I. INAGAKI and H. WADA, Physiol. Behav. 51 391-394(1992).
10. 10. J.-S. LIN, K. SAKAI, G. VANNI-MERCIER, J.-M. ARRANG, M. GARBARG, J.-C. SCHWARTZ and M. JOUVET, Brain Res. 528 325-330(1990).
11. 11. J.-S. LIN, Y. HOU, K. SAKAI and M. JOUVET, J. Neuroscience 16 1523-15 37(1996).
12. 12. P. SERVO, K.E. BARKE, L.B. HOUGH and C.H. VANDREWOLF, BRAIN RES. 641 311-318 (1994).
13. 13. T. SAKATA, K. OOMUMA, K. FUKUNAGA, K. FUJIMOTO, H. YOSHI-MASTSU, T. SHIRAISHI and H. WADA Brain Res., 441 403-408(1988).
14. 14. T. DOI, T. SAKATA, H. YOSHIMATSU, H. MACHIDORI and M. KUROKAWA, Brain Res. 641 311-318(1994).
15. 15. L. TUOMISTO and U. TACKE, Neuropharmacology 25 955-958(1986).
16. 16. H. YOKOYAMA, K. ONODERA, K. IINUMA and T. WATANABE, Eur. J. Pharmacol. 234 129-133(1993).
17. 17. R. CACABELOS and A. ALVAREZ, Agents Actions 33 131-134(1991).
18. 18. C. KAMEI, Y. OKUMURA and K. TASAKA, Psychopharmacology, 111 376-382(1993).
19. 19. J. KOLLONITSCH, L.M. PERKINS, AA. PATCHETT, G.A. DOLDOURAS, S. MARBURG, D.E. DUGGAN, A.L. MAYCOCK and S.D. ASTER, Nature 274 906-908 (1978).
20. 20. T. WATANABE, A. YAMATODANI, K. MAEYAMA and H. WADA,Trends Pharmacol. Sci. 11 363-367(1990).
21. 21. M. GARBARG, G. BARBIN, E. RODERGAS and J.-C. SCHWARTZ, J. Neurochem. 35 1045-1052 (1980)
22. 22. A. YAMATODANI, H. FUKUDA, H. WADA, T. IWAEDA and T. WATANABE, J. Chromatog. 344 115-123(1985).
23. 23. A. Van HARREVELD and E. FIFKOVA, Brain Res. 81 455-467 (1974).
24. 24. J. W. JOHNSON and P. ASCHER, Nature 325 329-331(1987).
25. 25. R. GRANGER, U. ST AUBULI, M. DAVIS, Y. PEREZ, L. NILSSON, G.A. ROGER and G. LYNCH, Synapse 5 326-329(1993).
26. 26. J.E. FINKESTEIN, J.M. HENGEMIHLE, D.K. INGRA M and H.L. PETRI, Pharmac. Biochem. Behav. 49 707-710(1994).
27. 27. E. SENBA, P.E. DADDONA, T. WATANABE, J.-Y. WU and J.I. NAGY, Neuroscience 5 3393-3402(1985)
28. 28. J.P. HUSTON, U. WAGNER and R.V. HASENOHRL, Behav. Brain Res. 83 79-105 (1997).